Skip to contentI
InspireMD, Inc.
I
NSPRInspireMD, Inc. Q3 2020 · 10-Q
Revenue$980.00K$980.00K+4.4% vs Q3 2019 Net Income-$2.23M-$2.23MN/M vs Q3 2019 EPS Diluted-$0.96-$0.96N/M vs Q3 2019 Gross Profit$298,000+132.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InspireMD, Inc. · CIK 1433607 · Engraved from SEC EDGAR
Operating Cash Flowderived-$3,044,000N/M Margins · derivedGross margin30.4%+16.8 pt vs Q3 2019
Operating margin-224.0%−11.3 pt vs Q3 2019
Net margin-227.9%−7.4 pt vs Q3 2019
ended Sep 30, 2020 · filed Nov 9, 2020 · 40 d after period end